Logo image of SRXH

SRX HEALTH SOLUTIONS INC (SRXH) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:SRXH - US08771Y4026 - Common Stock

0.2808 USD
+0.01 (+2.67%)
Last: 11/24/2025, 12:58:18 PM
Fundamental Rating

1

SRXH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Consumer Staples Distribution & Retail industry. SRXH may be in some trouble as it scores bad on both profitability and health. SRXH has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SRXH had negative earnings in the past year.
SRXH had a negative operating cash flow in the past year.
In the past 5 years SRXH reported 4 times negative net income.
In the past 5 years SRXH reported 4 times negative operating cash flow.
SRXH Yearly Net Income VS EBIT VS OCF VS FCFSRXH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of SRXH (-47.34%) is worse than 89.74% of its industry peers.
Industry RankSector Rank
ROA -47.34%
ROE N/A
ROIC N/A
ROA(3y)-79.59%
ROA(5y)-70.15%
ROE(3y)-316.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SRXH Yearly ROA, ROE, ROICSRXH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

1.3 Margins

SRXH has a Gross Margin of 34.80%. This is amongst the best in the industry. SRXH outperforms 82.05% of its industry peers.
SRXH's Gross Margin has been stable in the last couple of years.
SRXH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y-0.26%
SRXH Yearly Profit, Operating, Gross MarginsSRXH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

0

2. Health

2.1 Basic Checks

SRXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SRXH has more shares outstanding
SRXH has more shares outstanding than it did 5 years ago.
SRXH has a better debt/assets ratio than last year.
SRXH Yearly Shares OutstandingSRXH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
SRXH Yearly Total Debt VS Total AssetsSRXH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

SRXH has an Altman-Z score of -6.47. This is a bad value and indicates that SRXH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SRXH (-6.47) is worse than 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.47
ROIC/WACCN/A
WACC7.68%
SRXH Yearly LT Debt VS Equity VS FCFSRXH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.33 indicates that SRXH may have some problems paying its short term obligations.
With a Current ratio value of 0.33, SRXH is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
A Quick Ratio of 0.26 indicates that SRXH may have some problems paying its short term obligations.
With a Quick ratio value of 0.26, SRXH is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.26
SRXH Yearly Current Assets VS Current LiabilitesSRXH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

SRXH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.29%, which is quite impressive.
SRXH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.31%.
The Revenue has been growing by 17.56% on average over the past years. This is quite good.
EPS 1Y (TTM)94.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.45%
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-8.73%
Revenue growth 5Y17.56%
Sales Q2Q%34.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y273.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SRXH Yearly Revenue VS EstimatesSRXH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SRXH Yearly EPS VS EstimatesSRXH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -10 -20 -30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRXH. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 1.06, which indicates a rather cheap valuation of SRXH.
100.00% of the companies in the same industry are more expensive than SRXH, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SRXH to the average of the S&P500 Index (34.42), we can say SRXH is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.06
SRXH Price Earnings VS Forward Price EarningsSRXH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRXH Per share dataSRXH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SRXH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SRX HEALTH SOLUTIONS INC

NYSEARCA:SRXH (11/24/2025, 12:58:18 PM)

0.2808

+0.01 (+2.67%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-10 2025-11-10
Earnings (Next)03-25 2026-03-25/amc
Inst Owners1.03%
Inst Owner ChangeN/A
Ins Owners20.55%
Ins Owner Change0%
Market Cap6.98M
Revenue(TTM)37.14M
Net Income(TTM)-16.09M
Analysts82.86
Price Target10.2 (3532.48%)
Short Float %6.78%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.06
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.15
EYN/A
EPS(NY)0.27
Fwd EY94.44%
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS1.49
BVpS-1.85
TBVpS-1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.8%
FCFM N/A
ROA(3y)-79.59%
ROA(5y)-70.15%
ROE(3y)-316.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y-0.26%
F-Score2
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.32%
Cap/Sales 5.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.26
Altman-Z -6.47
F-Score2
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)14.78%
Cap/Depr(5y)14.84%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.45%
EPS Next Y273.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-8.73%
Revenue growth 5Y17.56%
Sales Q2Q%34.04%
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-140.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.4%
OCF growth 3YN/A
OCF growth 5YN/A

SRX HEALTH SOLUTIONS INC / SRXH FAQ

What is the ChartMill fundamental rating of SRX HEALTH SOLUTIONS INC (SRXH) stock?

ChartMill assigns a fundamental rating of 1 / 10 to SRXH.


What is the valuation status for SRXH stock?

ChartMill assigns a valuation rating of 4 / 10 to SRX HEALTH SOLUTIONS INC (SRXH). This can be considered as Fairly Valued.


What is the profitability of SRXH stock?

SRX HEALTH SOLUTIONS INC (SRXH) has a profitability rating of 1 / 10.


How financially healthy is SRX HEALTH SOLUTIONS INC?

The financial health rating of SRX HEALTH SOLUTIONS INC (SRXH) is 0 / 10.


Is the dividend of SRX HEALTH SOLUTIONS INC sustainable?

The dividend rating of SRX HEALTH SOLUTIONS INC (SRXH) is 0 / 10 and the dividend payout ratio is 0%.